THYROCARE

THYROCARE TECHNOLOGIES

Small Cap BSE: 539871 NSE: THYROCARE
₹641.00
9.6 (1.52%)
As on 04 December, 2022 | 15:04

Thyrocare Technologies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in THYROCARE TECHNOLOGIES

Start SIP

Thyrocare Technologies Share Price

Thyrocare Technologies Share Returns

  • Over 1 Month -1.41%
  • Over 3 Month 3.39%
  • Over 6 Month 1.4%
  • Over 1 Year -41.12%

Thyrocare Technologies Key Statistics

P/E Ratio 42.5
PEG Ratio -0.7
Market Cap Cr 3,393
Price to Book Ratio 6.4
EPS 28.1
Dividend 2.3
Relative Strength Index 52.22
Money Flow Index 58.08
MACD Signal -10.29
Average True Range 15.8

Thyrocare Technologies Investment Rating

  • Master Rating:
  • Thyrocare Technologies has an operating revenue of Rs. 510.72 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 39% is great, ROE of 33% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 38 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 98 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Thyrocare Technologies Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 125119123110169159139
Operating Expenses Qtr Cr 96858774828988
Operating Profit Qtr Cr 30343736877151
Depreciation Qtr Cr 8897766
Interest Qtr Cr 1111110
Tax Qtr Cr 8697211912
Net Profit Qtr Cr 14202023614835

Thyrocare Technologies Technicals

EMA & SMA

Current Price
641.
9.6 (1.52%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 632.52
  • 50 Day
  • 645.63
  • 100 Day
  • 664.1
  • 200 Day
  • 728.07
  • 20 Day
  • 635.11
  • 50 Day
  • 656.18
  • 100 Day
  • 649.17
  • 200 Day
  • 701.58

Thyrocare Technologies Resistance and Support

PIVOT
₹632.52
Resistance
First Resistance 637.04
Second Resistance 642.67
Third Resistance 647.19
RSI 52.22
MFI 58.08
MACD Single Line -10.29
MACD -7.82
Support
First Resistance 626.89
Second Resistance 622.37
Third Resistance 616.74

Thyrocare Technologies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 44,742 3,042,009 67.99
Week 27,716 1,736,974 62.67
1 Month 43,354 2,035,466 46.95
6 Month 102,824 4,330,943 42.12

Thyrocare Technologies Result Highlights

Thyrocare Technologies Synopsis

NSE-Medical-Services

Thyrocare Tech. is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 561.53 Cr. and Equity Capital is Rs. 52.90 Cr. for the Year ended 31/03/2022. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.
Market Cap 3,389
Sales 478
Shares in Float 1.53
No of funds 76
Yield 2.34
Book Value 6.5
U/D Vol ratio 0.8
LTDebt / Equity
Alpha -0.21
Beta 0.44

Thyrocare Technologies

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 71.14%71.18%71.18%
Mutual Funds 6.81%4.72%4.56%
Insurance Companies 1.85%1.96%1.96%
Foreign Portfolio Investors 10.42%12.82%12.68%
Financial Institutions/ Banks
Individual Investors 7.28%6.72%6.65%
Others 2.5%2.6%2.97%

Thyrocare Technologies Management

Name Designation
Mr. Rahul Guha Managing Director & CEO
Mr. Dharmil Sheth Non Executive Director
Mr. Hardik Dedhia Non Executive Director
Mr. Dhaval Shah Non Executive Director
Mr. Gopalkrishna Shivram Hegde Independent Director
Mr. Vishwas Kulkarni Independent Director
Dr. Neetin S Desai Independent Director
Dr. Indumati Gopinathan Independent Director

Thyrocare Technologies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Thyrocare Technologies Corporate Action

Date Purpose Remarks
2022-11-11 Quarterly Results
2022-08-01 Quarterly Results
2022-04-29 Audited Results & Dividend
2022-02-12 Quarterly Results
2021-11-13 Quarterly Results
Date Purpose Remarks
2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

Thyrocare Technologies MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 22844
Nippon India Pharma Fund - Growth 4786
UTI Dividend Yield Fund Regular Plan Growth 2865
Nippon India Retirement Fund - Wealth Creation Scheme - Regular Growth 2400
Union Small Cap Fund Regular Growth 1404

Thyrocare Technologies FAQs

What is Share Price of Thyrocare Technologies ?

Thyrocare Technologies share price is ₹641 As on 04 December, 2022 | 14:50

What is the Market Cap of Thyrocare Technologies ?

The Market Cap of Thyrocare Technologies is ₹3392.8 Cr As on 04 December, 2022 | 14:50

What is the P/E ratio of Thyrocare Technologies ?

The P/E ratio of Thyrocare Technologies is 42.5 As on 04 December, 2022 | 14:50

What is the PB ratio of Thyrocare Technologies ?

The PB ratio of Thyrocare Technologies is 6.4 As on 04 December, 2022 | 14:50

Q2FY23